1. 1282PResponder analysis based on patient-reported outcomes (PROs) and clinical endpoints (CEPs) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab. (23rd October 2018) Authors: D'Angelo, S P; Fofana, F; Schlichting, M; Henry-Szatkowski, M; Hennessy, M; Bharmal, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1291PCost-effectiveness (CE) of avelumab vs standard care (SC) for the treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC). (23rd October 2018) Authors: Bharmal, M; Amin, A; Stapelkamp, C; Pescott, C; Hatswell, A; Lilley, C; Bullement, A; Willis, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗